Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs

  • Catharina Margrethe Lerche | cler0001@bbh.regionh.dk Bispebjerg University Hospital, Denmark.
  • Hans Christian Wulf Bispebjerg University Hospital, Denmark.

Abstract

Topical therapies constitute the mainstay of dermatological treatments for skin disorders, such as atopic dermatitis, contact dermatitis, psoriasis, or acne. Since some of these diseases are often chronic, treatment duration may last for years and may even last the patient’s entire lifetime. Obviously, such long-term therapy may raise safety concerns, which also include the potential photocarcinogenic effect. Most patients are exposed to ultraviolet radiation (UVR) during leisure, work, vacations, or in tanning beds. Additionally, the patients may receive UVR via UVB phototherapy or psoralens plus UVA radiation (PUVA). The use of immunosuppressant’s, such as corticosteroids and calcineurin inhibitors, has markedly increased. Patients with skin diseases have benefited from both systemic and topical treatment of both new and established drugs. The issue of a black box warning by the US Food and Drug Administration has increased concerns about photocarcinogenesis, which raises the question: “Are these drugs safe?” This review focuses on the mechanism of action and photocarcinogenic potential of commonly used topical treatments, such as corticosteroids, calcineurin inhibitors, and vitamin D analogs.

Downloads

Download data is not yet available.

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Author Biography

Catharina Margrethe Lerche, Bispebjerg University Hospital
Department of Dermatology, PhD-student
Published
2010-09-14
Section
Reviews
Keywords:
Pimecrolimus, tacrolimus, calcineurin inhibitor, corticosteroid, vitamin D analog
Statistics
Abstract views: 1273

PDF: 353
HTML: 155
Share it
Bookmark and Share
How to Cite
Lerche, C., & Wulf, H. C. (2010). Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs. Dermatology Reports, 2(2), e13. https://doi.org/10.4081/dr.2010.e13